We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
1
1National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke1990; 21: 637–76.Google Scholar
2
2Hankey, GJ, Warlow, CP. Transient ischaemic attacks of the brain and eye. London: Baillière Tindall, WB Saunders, 1994.Google Scholar
3
3Dennis, MS, Bamford, JM, Sandercock, PAG, Molyneux, A, Warlow, CP. Computerised tomography in patients with transient ischaemic attacks: when is a transient ischaemic attack not a transient ischaemic attack but a stroke?J Neurol1990; 237: 257–61.CrossRefGoogle Scholar
4
4Hatano, S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ1976; 54: 541–53.Google Scholar
5
5Bamford, J, Sandercock, P, Dennis, M, Burn, J, Warlow, C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981–1986. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry1990; 53: 16–22.Google Scholar
6
6Anderson, CS, Jamrozik, KD, Burvill, PW, Chakera, TMH, Johnson, GA, Stewart-Wynne EG: Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke study, 1989–1990. Med J Aust1993; 158: 85–89.CrossRefGoogle ScholarPubMed
7
7Dennis, MS, Bamford, JM, Sandercock, PAG, Warlow, CP. A comparison of risk factors and prognosis for transient ischaemic attacks and minor ischaemic strokes. The Oxfordshire Community Stroke Project. Stroke1989; 20: 1494–99.CrossRefGoogle ScholarPubMed
8
8Dennis, M, Bamford, J, Sandercock, P, Warlow, C. Prognosis of transient ischaemic attacks in the Oxfordshire Community Stroke Project. Stroke1990; 21: 848–53.CrossRefGoogle ScholarPubMed
9
9Hankey, GJ, Slattery, JM, Warlow, CP. The prognosis of hospital-referred transient ischaemic attacks. J Neural Neurosurg Psychiatry1991; 54: 793–802.Google Scholar
10
10Dennis, MS, Burn, JPS, Sandercock, PAG, Bamford, JM, Wade, DT, Warlow, CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke1993; 24: 796–800.CrossRefGoogle ScholarPubMed
12Secretary of State for Health. The Health of the Nation. London: HMSO, 1991.Google Scholar
13
13Martin, J, Meltzer, H, Elliot, D. For the Office of population censuses and surveys: OPCS surveys of disability in Great Britain, Report 1. The prevalence of disability among adults. London: HMSO, 1988.Google Scholar
14
14Bamford, J, Sandercock, P, Dennis, M et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981–1986. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry1988; 51: 1373–80.CrossRefGoogle ScholarPubMed
15
15Anderson, CS, Jamrozik, KD, Burvill, PW, Chakera, TMH, Johnson, GA, Stewart-Wynne EG. Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989–1990. Med J Aust1993; 158: 80–84.CrossRefGoogle ScholarPubMed
16
16Wade, DT, Langton-Hewer, R, Skilbeck, CE, David, RM. Stroke. A critical approach to diagnosis, treatment and management. London: Chapman & Hall, 1985.Google Scholar
18Malmgren, R, Bamford, J, Warlow, C, Sandercock, P, Slattery, J. Projecting the number of patients with first-ever strokes and patients newly handicapped by stroke in England and Wales. Br Med J1989; 298: 656–60.CrossRefGoogle ScholarPubMed
19
19Carstairs, V. Stroke: resource consumption and the cost to the community. In: Gillingham, FJ, Mawdsley, C, Williams, AE eds. Stroke proceedings of the ninth international Pfizer symposium. Edinburgh: Churchill Livingstone, 1976: 516–28.Google Scholar
20
20Isard, PA, Forbes, JF. The cost of stroke to the National Health Service in Scotland. Cerebrovasc Dis1992; 2: 47–50.CrossRefGoogle Scholar
21
21Hankey, GJ, Warlow, CP. The role of imaging in the management of cerebral and ocular ischaemia. Neuroradiology1991; 33: 381–90.CrossRefGoogle ScholarPubMed
22
22Dennis, MS, Bamford, JM, Sandercock, PAG, Warlow, CP. Incidence of transient ischaemic attacks in Oxfordshire, England. Stroke1989; 20: 333–39.CrossRefGoogle ScholarPubMed
23
23Kraaijeveld, CL, van Gijn, J, Schouten, HJA, Staal, A. Interobserver agreement for the diagnosis of transient ischaemic attacks. Stroke1984; 15: 723–25.CrossRefGoogle Scholar
24
24Kessler, C, Freyberger, HJ, Dittmann, V, Ringelstein, EB. Interrater reliability in the assessment of neurovascular diseases. Cerebrovasc Dis1991; 1: 43–48.Google Scholar
25
25Dennis, MS, Warlow, CP. Migraine aura without headache: transient ischaemic attack or not?J Neural Neurosurg Psychiatry1992; 55: 437–40.Google Scholar
26
26Olesen, J, Friberg, L, Olsen, TK et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain1993; 116: 187–202.CrossRefGoogle ScholarPubMed
27
27O'Sullivan, F, Rossor, M, Elston, JS. Amaurosis fugax in young people. Br J Ophthalmol1992; 76: 660–62.CrossRefGoogle ScholarPubMed
28
28Rao, ML, Stefan, H, Bauer, J. Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels. Neuroendocrinology1989; 49: 33–39.CrossRefGoogle Scholar
29
29Hodges, JR, Warlow, CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neural Neurosurg Psychiatry1990; 53834–43.CrossRefGoogle ScholarPubMed
30
30UK-TIA Study Group. Intracranial tumours that mimic transient cerebral ischaemia: lessons from a large multicentre trial. J Neural Neurosurg Psychiatry1993; 56: 563–66.CrossRefGoogle Scholar
31
31Bogousslavsky, J, Vinuela, F, Barnett, HJM, Drake, CG: Amaurosis fugax as the presenting manifestation of dural arteriovenous malformation. Stroke1985; 16: 891–93.Google Scholar
32
32Moster, ML, Johnston, DE, Reinmuth, OM. Chronic subdural haematoma with transient neurological deficits: a review of 15 cases. Ann Neurol1983; 14: 539–42.CrossRefGoogle ScholarPubMed
33
33Twomey, JA, Espir, MLE. Paroxysmal symptoms as the first manifestations of multiple sclerosis. J Neural Neurosurg Psychiatry1980; 43: 296–304.CrossRefGoogle ScholarPubMed
34
34Rother, J, Schreiner, A, Wentz, K-U, Hennerici, M. Hypoglycaemia presenting as basilar artery thrombosis. Stroke1992; 23: 112–13.CrossRefGoogle ScholarPubMed
35
35Longo, DL, Witherspoon, JM. Focal neurological symptoms in hypercalcaemia. Neurology1980; 30: 200–201.CrossRefGoogle Scholar
36
36Ruby, RJ, Burton, JR. Acute reversible hemiparesis and hyponatraemia. Lancet1977; 1: 1212.Google Scholar
37
37Dawson, DM, Hallett, M, Millender, LH. Entrapment neuropathies, second edition. Boston: Little, Brown & Co, 1990: 333.Google Scholar
38
38Blau, JN, Wiles, CM, Solomon, FS. Unilateral somatic symptoms due to hyperventilation. Br Med J1983; 286: 1108.CrossRefGoogle ScholarPubMed
39
39Bogousslavsky, J, Regli, F. Vertebrobasilar transient ischaemic attacks in internal carotid artery occlusion or tight stenosis. Arch Neurol1985; 42: 64–68.CrossRefGoogle ScholarPubMed
40
40Sandercock, PAG, Allen, CMC, Corston, RN, Harrison, MJG, Warlow, CP. Clinical diagnosis of intracranial haemorrhage using Guy's Hospital score. Br Med J1985; 291: 1675–77.CrossRefGoogle ScholarPubMed
41
41Poungvarin, N, Viriyavejakul, A, Komontri, C. Siriraj stroke score and validation study to distinguish supratentorial intracerebral haemorrhage from infarction. Br Med J1991; 302: 1565–67.Google Scholar
42
42Donnan, GA. Investigation of patients with stroke and transient ischaemic attacks. Lancet1992; 339: 473–77.CrossRefGoogle ScholarPubMed
43
43Dennis, MS, Bamford, JM, Molyneux, AJ, Warlow, CP. Rapid resolution of signs of primary intracerebral haemorrhage in computed tomograms of the brain. Br Med M1987;295: 379–81.CrossRefGoogle ScholarPubMed
44
44Edelman, RR, Warach, S. Magnetic resonance imaging (second of two parts). N Engl J Med1993; 328: 785–91.Google Scholar
45
45Hopkins, A, Menken, M, DeFriese, GH, Feldman, RG. Differences in strategies for the diagnosis and treatment of neurologic disease among British and American neurologists. Arch Neurol1989; 46: 1142–48.Google Scholar
46
46UK-TIA Study Group. Variation in the use of angiography and carotid endarterectomy by neurologists in the UK-TIA Aspirin Trial. Br Med J1983; 286: 514–17.Google Scholar
47
47Hankey, GJ, Warlow, CP. Cost-effective investigation of patients with suspected transient ischaemic attacks. J Neural Neurosurg Psychiatry1992; 55: 171–76.CrossRefGoogle ScholarPubMed
52Hommel, M, Besson, G, Le Bas, JF et al. Prospective study of lacunar infarction using magnetic resonance imaging. Stroke1990; 21: 546–54.Google Scholar
53
53Waterston, JA, Brown, MM, Butler, P, Swash, M. Small deep cerebral infarcts associated with occlusive internal carotid artery disease. Arch Neurol1990; 47: 953–57.Google Scholar
54
54Hankey, GJ, Khangure, MS, Stewart-Wynne, EG. Detection of basilar artery thrombosis by computed tomography. Clin Radiol1988; 39: 140–43.CrossRefGoogle ScholarPubMed
55
55Virapongse, C, Cazenave, C, Quisling, R, Sarwar, M, Hunter, S. The empty delta sign. Frequency and significance in 76 cases of dural sinus thrombosis. Radiology1987; 162: 779–85.Google Scholar
56
56Woo, J, Lam, CWK, Kay, R, Wong, HY, Teoh, R, Nicholls MG. Acute and long-term changes in serum lipids after acute stroke. Stroke1990; 21: 1407–11.CrossRefGoogle ScholarPubMed
57
57Sandercock, PAG, Warlow, CP, Jones, LN, Starkey, IR. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. Br Med J1989; 298: 75–80.Google Scholar
58
58Hughes, GRV: The antiphospholipid syndrome: ten years on. Lancet1993; 342: 341–44.CrossRefGoogle Scholar
59
59Greaves, M. Coagulation abnormalities and cerebral infarction. J Neurol Neurosurg Psychiatry1993; 56: 433–39.Google Scholar
60
60European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet1991; 337: 1235–43.CrossRefGoogle Scholar
61
61North American Symptomatic Carotid Endarterectomy Trial (NASCET) collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med1991; 325: 445–53.CrossRefGoogle Scholar
62
62Hankey, GJ, Warlow, CP. Symptomatic carotid ischaemic events: safest and most cost-effective way of selecting patients for angiography, before carotid endarterectomy. Br Med J1990; 300: 1485–91.Google Scholar
63
63Hu, H-H, Sheng, W-Y, Yen, M-Y, Lai, S-T, Teng, MM-H: Colour Doppler imaging of orbital arteries for detection of carotid occlusive disease. Stroke1993;24: 1196–203.CrossRefGoogle ScholarPubMed
64
64Humphrey, P, Sandercock, P, Slattery, J. A simple method to improve the accuracy of non-invasive ultrasound in selecting TIA patients for cerebral angiography. J Neurol Neurosurg Psychiatry1990; 53: 966–71.CrossRefGoogle ScholarPubMed
65
65Lewis, BD, James, EM, Welch, TJ. Current applications of Duplex and color Doppler ultrasound imaging: carotid and peripheral vascular system. Mayo Clin Proc1989; 64: 1147–57.CrossRefGoogle ScholarPubMed
69Hankey, GJ, Warlow, CP, Molyneux, AJ. Complications of cerebral angiography for patients with mild carotid territory ischaemia being considered for carotid endarterectomy. J Neurol Neurosurg Psychiatry1990; 53: 542–48.CrossRefGoogle ScholarPubMed
70
70Davies, KN, Humphrey, PR. Complications of cerebral angiography in patients with symptomatic carotid territory ischaemia screened by carotid ultrasound. J Neurol Neurosurg Psychiatry1993; 56: 967–72.CrossRefGoogle ScholarPubMed
72DeRook, FA, Comess, KA, Albers, GW. Popp, RL. Transoesophageal echocardiography in the evaluation of stroke. Ann Intern Med1992; 117: 922–32.Google Scholar
73
73Rose, G. The strategy of preventive medicine. Oxford: Oxford University Press, 1992.Google Scholar
74
74Shaper, AG, Phillips, AN, Pocock, SJ, Walker, M, Macfarlane, PW. Risk factors for stroke in middle aged British men. Br Med J1991; 302: 1111–15.Google Scholar
75
75Donnan, GA, You, R, Thrift, A, McNeil, JJ. Smoking as a risk factor for stroke. Cerebrovasc Dis1993; 3: 129–38.Google Scholar
76
76Alderman, MH. Blood pressure management: individualised treatment based on absolute risk and the potential for benefit. Ann Intern Med1993; 119: 329–35.Google Scholar
77
77MacMahon, S, Peto, R, Cutler, J et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet1990; 335: 765–74.CrossRefGoogle ScholarPubMed
78
78Collins, R, Peto, R, MacMahon, S et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet1990; 335: 827–38.Google Scholar
79
79Hankey, GJ, Slattery, JM, Warlow, CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?J Neural Neurosurg Psychiatry1992; 55: 640–52.Google Scholar
80
80Antiplatelet Trialists Collaboration: Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J1994; 308: 81–106.CrossRefGoogle Scholar
81
81The SALT Collaborative Group (Britton, M, Elwin, C-E, Helmers, C et al. ) Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischemie events. Lancet1991; 338: 1345–49.Google Scholar
82
82The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 versus 283 mg a day) in patients after a transient ischaemic attack or minor ischaemic stroke. N Engl J Med1991; 325: 1261–66.CrossRefGoogle Scholar
83
83European Atrial Fibrillation Trial Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet1993; 342: 1255–62.Google Scholar
84
84Petersen, P, Boysen, G, Godfredsen, J, Andersen, E, Andersen, B. Placebo-controlled randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet1988; 1: 175–79.Google Scholar
85
85The Stroke Prevention in Atrial Fibrillation Study Group. The stroke prevention in atrial fibrillation study: final results. Circulation1991; 84: 527–39.CrossRefGoogle Scholar
86
86The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med1990; 323: 1505–11.CrossRefGoogle Scholar
87
87Connolly, SJ, Laupacis, A, Gent, M, Roberts, RS, Cairns, JA, Joyner, C, for the CAFA Study Coinvestigators. Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol1991; 18: 349–55.CrossRefGoogle Scholar
88
88Ezekowitz, MD, Bridgers, SL, James, KE et al. for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation (SPINAF) Investigators. Warfarin in the prevention of stroke associated with atrial fibrillation. N Engl J Med1992; 327: 1406–f12.CrossRefGoogle Scholar
89
89Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet1994; 343: 687–91.Google Scholar
90
90Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: clinical features of patients at risk. Ann Intern Med1992; 116: 1–5.CrossRefGoogle Scholar
91
91Clagett, GP, Youkey, JR, Brigham, RA et al. Asymptomatic cervical bruit and abnormal ocular plethysmography: a prospective study comparing two approaches to management. Surgery1984; 96: 823–30.Google ScholarPubMed
92
92The CASANOVA Study Group. Carotid surgery versus medical therapy in asymptomatic carotid stenosis. Stroke1991; 22: 1229–35.Google Scholar
93
93Mayo Asymptomatic Carotid Endarterectomy Group. Results of a randomised controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo Clin Proc1992; 67: 513–18.CrossRefGoogle Scholar
94
94Hobson, RWII, Weiss, DG, Fields WS et al. and the Veterans Affairs Cooperative Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med1993; 328: 221–27.Google Scholar
95
95Asymptomatic Carotid Atherosclerosis Study Group. Study design for randomised prospective trial of carotid endarterectomy for asymptomatic atherosclerosis. Stroke1989; 20: 844–49.CrossRefGoogle Scholar
96
96EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischaemic stroke. N Engl J Med1985; 313: 1191–200.CrossRefGoogle Scholar
97
97Brown, MM, Butler, P, Gibbs, J, Swash, M, Waterston, J. Feasibility of percutaneous transluminal angioplasty for carotid artery stenosis. J Neurol Neurosurg Psychiatry1990; 53: 238–43.Google Scholar
98
98Sandercock, P, Willems, H. Medical treatment of acute ischaemic stroke. Lancet1992; 339: 537–39.CrossRefGoogle ScholarPubMed
99
99Wardlaw, JM, Warlow, CP. Thrombolysis in acute ischaemic stroke. Does it work?Stroke1992; 23: 1826–39.CrossRefGoogle ScholarPubMed
100
100Sandercock, PAG, van den Belt, AGM, Lindley, RI, Slattery, J. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatry1993; 56: 17–25.Google Scholar
101
101Scatton, B, Carter, C, Benavides, J, Giroux, C. N-Methyl-D-Aspartate receptor antagonists: a novel therapeutic perspective for the treatment of ischaemic brain injury. Cerebrovasc Dis1991; 1: 121–35.CrossRefGoogle Scholar
102
102Czlonkowska, A, Mendel, T, Baranska-Gieruszcak, M. Naloxone in acute ischaemic stroke: double blind controlled study. J Neurol1990; 237: 153.Google Scholar
103
103Schmidley, JW. Free radicals in central nervous system ischaemia. Stroke1990; 21: 1086–90.CrossRefGoogle Scholar
104
104Argentino, C, Sacchetti, ML, Toni, D et al. GM1 Ganglioside therapy in acute ischaemic stroke. Stroke1989; 20: 1143–49.CrossRefGoogle Scholar
105
105Goldstein, LB, Davis, JN. Restorative neurology. Drugs and recovery following stroke. Stroke1990; 21: 1636–39.Google Scholar
106
106Pickard, JD, Murray, GD, Illingworth, R et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage. British aneurysm nimodipine trial. Br Med J1989; 298: 636–42.CrossRefGoogle ScholarPubMed